Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prime Editing for Inherited Retinal Diseases
Bruna Lopes da Costa, Sarah R. Levi, Eric Eulau, et al.
Frontiers in Genome Editing (2021) Vol. 3
Open Access | Times Cited: 23

Showing 23 citing articles:

Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Selina Drag, Farokh Dotiwala, Arun K. Upadhyay
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 7, pp. 39-39
Open Access | Times Cited: 60
Precision genome editing in the eye
Susie Suh, Elliot H. Choi, Aditya Raguram, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 39
Open Access | Times Cited: 36
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions
Ruofei Yuan, Bo Wang, Ying Wang, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 257-276
Open Access | Times Cited: 7
Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases
Fabio Bigini, Soo Hyeon Lee, Young Joo Sun, et al.
Vision Research (2023) Vol. 213, pp. 108317-108317
Open Access | Times Cited: 12
Mechanisms underlying phenotypic variation in neurogenetic disorders
Jean‐Marc Burgunder
Nature Reviews Neurology (2023) Vol. 19, Iss. 6, pp. 363-370
Closed Access | Times Cited: 11
Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
Lucia Finocchio, Marco Zeppieri, Andrea Gabai, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3221-3221
Open Access | Times Cited: 10
Rekindling Vision: Innovative Strategies for Treating Retinal Degeneration
Irfan Khan, Faiza Ramzan, Haroon Tayyab, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4078-4078
Open Access
CRISPR/Cas therapeutic strategies for autosomal dominant disorders
Salvatore Marco Caruso, Peter M. J. Quinn, Bruna Lopes da Costa, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 15
Optogenetics and Targeted Gene Therapy for Retinal Diseases: Unravelling the Fundamentals, Applications, and Future Perspectives
Merve Kulbay, Nicolas Tuli, Arjin Akdag, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4224-4224
Open Access | Times Cited: 3
Clinical and Therapeutic Evaluation of the Ten Most Prevalent CRB1 Mutations
Bruna Lopes da Costa, Masha Kolesnikova, Sarah R. Levi, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 385-385
Open Access | Times Cited: 8
Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime Editing
Bruna Lopes da Costa, Laura A. Jenny, Irene H. Maumenee, et al.
Advances in experimental medicine and biology (2023), pp. 103-107
Closed Access | Times Cited: 4
The Future of Nanomaterials Tackling the Challenge of Delivering Nucleic Acids to the Retina
José Hurst, Friederike Adams, Sven Schnichels
Advanced Functional Materials (2024)
Closed Access | Times Cited: 1
Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Tiffany Yee, Katherine J. Wert
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12375-12375
Open Access | Times Cited: 6
Toward Retinal Organoids in High-Throughput
Stefan E. Spirig, Magdalena Renner
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 3, pp. a041275-a041275
Closed Access | Times Cited: 3
Generation of an Avian Myeloblastosis Virus (AMV) Reverse Transcriptase Prime Editor
Yi‐Ting Tsai, Bruna Lopes da Costa, Salvatore Marco Caruso, et al.
Advances in experimental medicine and biology (2023), pp. 109-114
Closed Access | Times Cited: 3
Prime Editing Strategy to Install the PRPH2 c.828+1G>A Mutation
Salvatore Marco Caruso, Yi‐Ting Tsai, Bruna Lopes da Costa, et al.
Advances in experimental medicine and biology (2023), pp. 97-102
Closed Access | Times Cited: 2
Gene Therapy for Rhodopsin Mutations
Alfred S. Lewin, Wayne C. Smith
Cold Spring Harbor Perspectives in Medicine (2022) Vol. 12, Iss. 9, pp. a041283-a041283
Open Access | Times Cited: 3
Gene therapies in pediatric ophthalmology
Alejandra Daruich, Matthieu P. Robert, Dominique Brémond‐Gignac
Frontiers in Ophthalmology (2023) Vol. 3
Open Access | Times Cited: 1
Gene and cell-based therapies for retinal and optic nerve disease
Edward P Esposito, Ian C. Han, Thomas V. Johnson
Handbook of clinical neurology (2024), pp. 243-262
Closed Access
Current and Future Directions in Developing Effective Treatments for PRPH2-Associated Retinal Diseases: A Workshop Report
Radha Ayyagari, Shyamanga Borooah, Todd A. Durham, et al.
Translational Vision Science & Technology (2024) Vol. 13, Iss. 10, pp. 16-16
Open Access
Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71
Betty W. Wu, Michael B. Yee, Ronald S. Goldstein, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 378-378
Open Access | Times Cited: 2
Therapeutic Gene Editing in Inherited Retinal Disorders
Jinjie Ling, Laura A. Jenny, Ashley Zhou, et al.
Cold Spring Harbor Perspectives in Medicine (2022) Vol. 13, Iss. 4, pp. a041292-a041292
Closed Access | Times Cited: 2
Update on gene therapies in pediatric ophthalmology
Dominique Brémond‐Gignac, Matthieu P. Robert, Alejandra Daruich
Archives de Pédiatrie (2023) Vol. 30, Iss. 8, pp. 8S41-8S45
Closed Access
Page 1

Scroll to top